Diagnosis of Bladder Cancer
As more injured patients consult an Actos lawyer about filing an Actos lawsuit against Takeda, users of the popular diabetes drug want to know: How does one receive a bladder cancer diagnosis?
Concerned patients also want to know the true risk of developing bladder cancer from Actos, and why they were not warned about the dangers before taking the top-selling medication.
Doctors take several steps to diagnose Actos bladder cancer
Bladder cancer is one of the hardest types of cancer to diagnose. If a doctor suspects that a patient may be suffering from bladder cancer due to coordinating symptoms, they will often take a patient history to determine the underlying risks.
Such a history involves a series of questions about a patient’s family health history, their individual health history and their general lifestyle. If certain risk factors are confirmed by this history, the doctor will likely perform a physical exam.
An exam may involve a cystoscopy, during which the doctor will insert a small camera into the patient’s bladder and visually inspect any possible abnormalities or other indications of potential bladder cancer.
If, after this battery of exams, the doctor has been unable to rule out bladder cancer, he or she may order biopsies or cultures to be examined by a laboratory. During a biopsy, the doctor will remove a sample from the bladder, and send it to a laboratory for further analysis.
A culture similarly involves a tissue sample; however, the sample is instead placed in a growth agent to assess if any pathogens are present. Both procedures can be uncomfortable and intrusive, but are often the only ways to confirm a diagnosis of bladder cancer.
FDA confirms risk of Actos side effects
In recent years, there has been increasing evidence of a link between bladder cancer diagnosis and use of the diabetes drug Actos. The drug, which is prescribed to patients suffering from type 2 diabetes, has come under such scrutiny that the FDA has issued a warning to doctors, recommending that they avoid prescribing Actos to patients with medical histories indicating a high risk of bladder cancer.
The increased risk of bladder cancer is now highlighted on the Actos side effects warning label.
Actos lawsuits will soon have their day in court
Recent Actos lawsuit actions brought against drug makers Takeda Pharmaceuticals and Eli Lilly and Co., many filed in Louisiana and California, have shone a spotlight on the risk of Actos cancer.
These lawsuits may soon go to trial, and plaintiffs, represented by an Actos lawyer, will have their chance to argue for substantial compensation for their cancer and other injuries related to Actos side effects.